Inventor · disambiguated record
Ryan Dellinger
Also filed as: DELLINGER RYAN · DELLINGER RYAN W
18 granted patents·12 pending applications·30 citations·filing 2012–2023
90Inventor score
Files withELYSIUM HEALTH INC18CHROMADEX INC8UNIV CALIFORNIA2BARTOS JEREMY1UNIV DE VALENCIA ESTUDI GENERAL1
Top patents by PatentIndex Score
30 records- 0189US12043616B2Crystalline forms of nicotinamide riboside chlorideELYSIUM HEALTH INC·Filed 2022·Granted Jul 23, 2024·2 cites·20 claims
- 0288US10000520B2B-vitamin and amino acid conjugates ofnicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereofCHROMADEX INC·Filed 2017·Granted Jun 19, 2018·6 cites·9 claims
- 0386US10934322B2B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereofCHROMADEX INC·Filed 2018·Granted Mar 2, 2021·4 cites·18 claims
- 0484US10280190B2Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof to enhance skin permeation in treating skin conditionsCHROMADEX INC·Filed 2016·Granted May 7, 2019·6 cites·26 claims
- 0582US11414407B2Crystalline forms of nicotinamide riboside chlorideELYSIUM HEALTH INC·Filed 2018·Granted Aug 16, 2022·2 cites·14 claims
- 0682US10183036B2Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as NAD+ increasing precursorsCHROMADEX INC·Filed 2017·Granted Jan 22, 2019·6 cites·8 claims
- 0777US11389468B2Nicotinamide riboside for use in treating or preventing liver damageELYSIUM HEALTH INC·Filed 2018·Granted Jul 19, 2022·1 cites·10 claims
- 0874US12433908B2Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy developmentCHROMADEX INC·Filed 2022·Granted Oct 7, 2025·0 cites·13 claims
- 0974US9980924B2Topical pterostilbene compositions for use in treating UV-induced loss of barrier function in skinUNIV CALIFORNIA·Filed 2015·Granted May 29, 2018·1 cites·13 claims
- 1073US11524022B2Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy developmentCHROMADEX INC·Filed 2020·Granted Dec 13, 2022·0 cites·22 claims
- 1170US12128060B2Nicotinamide riboside for use in treating or preventing liver damageELYSIUM HEALTH INC·Filed 2022·Granted Oct 29, 2024·0 cites·8 claims
- 1270US10857172B2Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy developmentCHROMADEX INC·Filed 2017·Granted Dec 8, 2020·0 cites·10 claims
- 1369US2023348521A1Methods of synthesizing nicotinamide ribosideELYSIUM HEALTH INC·Filed 2023·Application pending·0 cites
- 1463US8841350B2Method for inducing UDP-glucuronosyltransferase activity using pterostilbeneBARTOS JEREMY·Filed 2012·Granted Sep 23, 2014·2 cites·18 claims
- 1563US2025171482A1Deacylation of carbohydrate compoundsELYSIUM HEALTH INC·Filed 2023·Application pending·0 cites
- 1662US2025127804A1Ribose linkers and conjugates thereofELYSIUM HEALTH INC·Filed 2023·Application pending·0 cites
- 1760US2024415862A1Methods for treatment of menopausal syndromesELYSIUM HEALTH INC·Filed 2022·Application pending·0 cites
- 1857US11629163B2Methods of synthesizing nicotinamide ribosideELYSIUM HEALTH INC·Filed 2018·Granted Apr 18, 2023·0 cites·5 claims
- 1956US11129843B2Treating and preventing kidney damageELYSIUM HEALTH INC·Filed 2018·Granted Sep 28, 2021·0 cites·45 claims
- 2053US10039725B2Method for treating non-melanoma skin cancer by inducing UDP-glucuronosyltransferase activity using pterostilbeneCHROMADEX INC·Filed 2014·Granted Aug 7, 2018·0 cites·22 claims
- 2148US2020261483A1Methods and compositions for treating cystic fibrosisELYSIUM HEALTH INC·Filed 2018·Application pending·0 cites
- 2247US2021177875A1Methods and compositions for treating childhood or teen obesityELYSIUM HEALTH INC·Filed 2018·Application pending·0 cites
- 2347US2021186996A1Methods and compositions for treating multiple sclerosisELYSIUM HEALTH INC·Filed 2018·Application pending·0 cites
- 2445US2020085849A1Methods and compositions for improving sleepELYSIUM HEALTH INC·Filed 2018·Application pending·0 cites
- 2542US12350283B2Methods and compositions for treating motor neuron diseasesUNIV DE VALENCIA ESTUDI GENERAL·Filed 2020·Granted Jul 8, 2025·0 cites·8 claims
- 2641US2020330496A1Methods and compositions for treating premature aging diseasesELYSIUM HEALTH INC·Filed 2018·Application pending·0 cites
- 2741US2020384004A1Methods and compositions for treating glaucomaELYSIUM HEALTH INC·Filed 2018·Application pending·0 cites
- 2841US2020330497A1Prevention and treatment of tdp-43 associated diseasesELYSIUM HEALTH INC·Filed 2018·Application pending·0 cites
- 2940US2016067193A1Topical pterostilbene compositions for use in treating uv-induced skin damage and hyperplasiaUNIV CALIFORNIA·Filed 2015·Application pending·0 cites
- 3038US11730751B2Treating and preventing motor neuron diseases using nicotinamide ribosideELYSIUM HEALTH INC·Filed 2018·Granted Aug 22, 2023·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Ryan Dellinger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →